USNA

USANA Health Sciences Inc. - 10-Q Summary

Business Context and Reporting Period

This filing is a Quarterly Report on Form 10-Q for the period ended September 27, 2008. USANA Health Sciences, Inc. operates as a direct selling company developing, manufacturing, and distributing nutritional and personal care products globally through a network of independent distributors ("Associates"). The company operates in one reportable segment: Direct Selling.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased slightly by 0.9% in Q3 and 1.1% for the nine-month period. Growth was driven by the East Asia region (up 24.3% in Q3) and favorable currency exchange rates, which offset declines in North America (down 3.0% in Q3) and Southeast Asia/Pacific.
• Profitability Decline: Income from continuing operations dropped 30.2% in Q3 and 25.9% for the nine-month period. This was primarily due to flat sales growth combined with increased operating expenses.
• Expense Increases: Selling, General, and Administrative (SG&A) expenses rose significantly. In Q3, SG&A increased by $3.7 million, driven by a $2.0 million increase in wages, $0.9 million in non-recurring legal fees related to a terminated tender offer, and higher depreciation and equity-based compensation.
• Associate Incentives: Associate incentives as a percentage of net sales increased to 41.6% in Q3 (from 40.5% in 2007) due to higher payout rates and new compensation plan enhancements.
• Customer Base: Total active Associates increased to 184,000 (up 2.2% YoY), while active Preferred Customers decreased to 73,000 (down 7.6% YoY). North America saw a decline in active Associates, attributed to economic uncertainty.

Outlook, Risks, and Unusual Items

• Tender Offer: A tender offer initiated by Unity Acquisition Corp. (indirectly owned by the Chairman) was terminated in July 2008 after the Board deemed the offers inadequate. Non-recurring legal fees associated with this process impacted earnings.
• Legal Proceedings: Two class-action lawsuits filed in 2007 were dismissed with prejudice in July and October 2008. Management believes remaining disputes will not materially impact financial results.
• Expansion: The company announced plans to begin operations in the Philippines in early 2009. Major facility expansions in Salt Lake City and Sydney, Australia, were substantially completed.
• Currency Risk: The company noted that a strengthening U.S. dollar is reversing previous benefits from currency exchange rates, potentially negatively impacting future sales and results.
• Liquidity: The company maintains a $40.0 million credit facility with $30.7 million drawn as of September 27, 2008. Management believes current cash and credit availability are sufficient for foreseeable needs.

Investor Verification Checklist

• North America Sales Trend: Verify the sustainability of sales declines in the U.S. and Canada amidst economic uncertainty and the impact of the "negative misinformation" mentioned in the filing.
• Expense Run Rate: Confirm whether the $0.9 million in legal fees and increased management compensation are one-time costs or indicative of a permanently higher cost structure.
• Currency Exposure: Assess the sensitivity of future earnings to a strengthening U.S. dollar, given that nearly 63% of sales are international.
• Associate Retention: Monitor the ratio of active Associates to Preferred Customers, as the decline in retail customers (Preferred) may signal reduced product consumption despite distributor growth.
• Debt Covenants: Review the company's compliance with EBITDA and debt coverage ratio covenants on its $40 million line of credit, which matures in May 2011.